Gilead Sciences issues $3.0B in senior notes across four tranches (4.250%-4.900%)

GILEAD SCIENCES, INC.

$500M 4.250% Senior Notes due 2028, $1B 4.400% due 2029, $1B 4.600% due 2031, $500M 4.900% due 2034.
Notes sold in public offering under Form S-3 shelf; proceeds for general corporate purposes incl. M&A.
Underwriting agreement dated May 14, 2026, with Barclays, BofA Securities, and Citigroup as reps.

item 1.01item 2.03item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.